CAPE TOWN, Nov 3 (Reuters) - Global pharmaceutical company, Pfizer, has partnered with South Africa's Biovac Institute to produce a potentially life-saving pneumonia vaccine for infants, a cabinet minister said on Tuesday.

The five-year partnership, officially announced at Biovac's Cape Town facility, will see technology transfer and skills upgraded for the production of 'Prevenar 13' vaccine on a sustainable basis, Science and Technology Minister Naledi Pandor said.

(Reporting by Wendell Roelf; Editing by James Macharia)